• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2011; 6(4): e18487.
Published online Apr 25, 2011. doi:  10.1371/journal.pone.0018487
PMCID: PMC3081807

Gains, Losses and Changes of Function after Gene Duplication: Study of the Metallothionein Family

Vincent Laudet, Editor

Abstract

Metallothioneins (MT) are small proteins involved in heavy metal detoxification and protection against oxidative stress and cancer. The mammalian MT family originated through a series of duplication events which generated four major genes (MT1 to MT4). MT1 and MT2 encode for ubiquitous proteins, while MT3 and MT4 evolved to accomplish specific roles in brain and epithelium, respectively. Herein, phylogenetic, transcriptional and polymorphic analyses are carried out to expose gains, losses and diversification of functions that characterize the evolutionary history of the MT family. The phylogenetic analyses show that all four major genes originated through a single duplication event prior to the radiation of mammals. Further expansion of the MT1 gene has occurred in the primate lineage reaching in humans a total of 13 paralogs, five of which are pseudogenes. In humans, the reading frame of all five MT1 pseudogenes is reconstructed by sequence homology with a functional duplicate revealing that loss of invariant cysteines is the most frequent event accounting for pseudogeneisation. Expression analyses based on EST counts and RT-PCR experiments show that, as for MT1 and MT2, human MT3 is also ubiquitously expressed while MT4 transcripts are present in brain, testes, esophagus and mainly in thymus. Polymorphic variation reveals two deleterious mutations (Cys30Tyr and Arg31Trp) in MT4 with frequencies reaching about 30% in African and Asian populations suggesting the gene is inactive in some individuals and physiological compensation for its loss must arise from a functional equivalent. Altogether our findings provide novel data on the evolution and diversification of MT gene duplicates, a valuable resource for understanding the vast set of biological processes in which these proteins are involved.

Introduction

When a particular gene is constrained to a specific function, the appearance of biological novelty demands genetic redundancy. Duplication of pre-existing genes may lead to the establishment of lineage-specific traits and to the development of novel biological functions [1], [2], [3], [4], [5]. However, the probability of widening biological functions (neofunctionalisation) is expectedly lower than the chance of inactivation (pseudogenisation) [6], [7], [8] as most amino-acid replacements are more likely neutral or deleterious, rather than leading to any particular adaptive change. Although the majority of gene duplicates result in pseudogenes, many remain functionally active longer than it would be expected by chance. This observation led to the development of the subfunctionalisation model [9], [10], according to which the accumulation of complementary loss-of-function mutations within regulatory segments of both members would facilitate their preservation while maintaining the original function. In case of preserving the parental function, duplicates may act as backup compensation copies to buffer against the loss of a functionally related gene [11], [12].

The current availability of several genome sequences allows the study of the evolutionary steps underlying the expansion of a gene family by detailed characterisation of lineage-specific expansions. We focused our attention on the mammalian metallothionein family for a number of reasons. MTs are metal-binding proteins involved in homeostasis and the transport of essential metals, more specifically, in protecting cells against heavy metals toxicity [13], [14], having thus a critical role in many biological processes. In mammals, four tandemly clustered genes (MT1 to MT4) are known. Although all genes encode for conserved peptide chains that retain 20 invariant metal-binding cysteines, MT3 and MT4 seem to have developed additional properties relatively to MT1 and MT2, such as protection against brain injuries [15], [16] and epithelial differentiation [17], respectively. Finally, during the evolution of the lineage that led to modern humans, MT1 has undergone further duplication events that have resulted in 13 younger duplicate isoforms [18]. The co-existence of younger and older duplicates is thus an opportunity to reconstruct the evolutionary history behind the divergence of the MT family in mammals.

Materials and Methods

Phylogenetic analyses

Coding sequences annotated as orthologues of the human MT genes were extracted from the Ensembl database (www.ensembl.org, release 56: Sep 2009) [19]. The final set of sequences (Table S1) does not include shortened sequences and those annotated in non-human species as representing the orthologue of distinct human MT1 genes. Codon sequences were aligned using MUSCLE [20], [21] incorporated in Geneious software v5.1.3 (http://www.geneious.com). Coding MT sequences from four fish species (Danio rerio, Oryzias latipes, Tetraodon nigroviridis and Takifugu rubripes), two birds (Gallus gallus and Taeniopygia guttata) and a reptile (Anolis carolinensis) were used to outgroup the phylogeny. Two methods were used to reconstruct the tree topology: maximum likelihood (ML) and Bayesian. In both cases, the model of nucleotide substitution used was HKY+G as determined in jModelTest [22]. The program BEAST [23] was used to estimate the Bayesian phylogeny in two runs (50 million generations each) using a Bioportal at the University of Oslo (http://www.bioportal.uio.no). The resulting log file was analyzed in Tracer [24]. The tree was obtained in TreeAnnotator from the BEAST software using a threshold for clade credibility of 0.5. For all the statistics obtained, the effective sample size (ESS) was always within the recommended threshold. The ML topology (Figure S1) was obtained with PHYML (http://www.bioportal.uio.no) [25] using the transition/transversion ratio, the proportion of invariable sites and the gamma parameter estimated by the program. Bootstrap branch support was estimated using 1000 data sets. Tree visualization and final edition were performed in FigTree v1.3.1 (http://tree.bio.ed.ac.uk/software/figtree).

Organization of the human and mouse MT family

The chromosomal organization of the MT family and flanking neighbours (BBS2 and NUP93) in humans and mice was performed using NCBI (Homo sapiens build 36.2 and Mus musculus build 37.1) [26] and Ensembl (release 56) genomic coordinates.

RT-PCR and expressed sequence tag (EST) analyses

Total RNA from 15 human tissues was obtained from Ambion (FirstChoice Human Total RNA Survey Panel). The complementary DNA (cDNA) was synthesized with random hexamer primers from 2 µg of human total RNA using the RETROscrip First Strand Synthesis Kit (Ambion) according to the manufacter's instructions. PCR primers used for amplification of the MT2, MT3 and MT4 transcripts were: 5′ATCCCAACTGCTCCTGCGCCG3′ (forward) and 5′CAGCAGCTGCACTTGTCCGACG3′ (reverse), 5′CTGAGACCTGCCCCTGCCCTT3′ (forward) and 5′TGCTTCTGCCTCAGCTGCCTCT3′ (reverse) and, 5′CCCCAGGGAATGTGTCTGCATGT3′ (forward) and 5′GGCACATTTGGCACAGCCCGG3′ (reverse), respectively. Samples were amplified with Qiagen Master Mix for 35 cycles at 95°C for 30 sec, 62°C for 30 sec and 72°C for 45 sec after an initial denaturation at 95°C for 15 min and followed by a final extension step of 10 min at 72°C. PCR products were then purified with ExoSAP-IT (USB Corporation, Ohio, USA) by incubation at 37°C for 15 min, followed by enzyme inactivation for 15 min at 85°C. The resulting purified fragments were sequenced using an ABI Big Dye Terminator Cycle Sequencing Ready Reaction kit (Applied Biosystems) and analysed in an ABI PRISM 3130xl (Applied Biosystems) for validation of the corresponding sequence.

ESTs were extracted from Unigene [26] as counts per million transcripts for each of the given tissues and displayed as log2 of transcripts per million. A unique EST for human MT4 is annotated in Unigene (GenBank BF759140.1) but since it contains intronic sequence was removed before plotting the data set. The heat-maps were constructed with an in-house tool using average linkage and the correlation of expression patterns as a measure of dissimilarity to build the hierarchical clusters.

Polymorphic population data

The Biomart tool [27] at the Ensembl database was used to assess the human polymorphic variability. Allelic and genotypic frequencies of Tyr30 (rs666636) and Trp31 (rs666647) were extracted from the HapMap project (http://www.hapmap.org). Genotypes for each population were also retrieved and analysed to evaluate the linkage disequilibrium between variants.

Structural homology modelling and visualisation

The crystal structure of the mouse Mt2 [28] (PDB code 4mt2) was used to model [29] both human native and mutation-carrying MT4 proteins following a previously reported methodology [30]. All the structures were displayed with PyMol (www.pymol.org).

Results

Evolutionary history of the MT cluster in mammals

The phylogeny of the MT family in mammals was reconstructed with Bayesian and maximum likelihood methods both approaches resulted in a similar topology (Fig. 1 and Figure S1) revealing the robustness of the inference. Tree topology, supported by high values of posterior probabilities (Fig. 1), point clearly to two rounds of duplication occurring at the MT family creating MT4 first and the ancestor of MT1/MT2/MT3. In a second round of duplication, MT3 diverged from the MT1/MT2 ancestor. These data are in agreement with previous observations [31] which concluded that MT duplication occurred before mammalian radiation. However, because MT genes from birds and reptiles group within the MT1/MT2/MT3 cluster, it is possible to consider a more ancient origin for MT4, and therefore, its loss in non-mammalian land vertebrates. An alternative explanation is that MT4 is thus a mammalian-specific gene which has been accumulating a pronounced number of replacements assigning its sequence to a basal position in both Bayesian and ML phylogenies.

Figure 1
Bayesian phylogenetic analysis of the MT family.

Extant mammalian genomes seem to carry a single copy of MT2, MT3 and MT4, while several MT1 copies are found in some species. The highest number of MT1 genes was found in the genome of primates indicating they have arisen in recent duplication events. The detailed genomic organization of the MT cluster in humans and mice provides a good example (Fig. 2). In both species, genes are oriented as cent-MT4-MT3-MT2-MT1-tel and flanked by BBS2 and NUP93, revealing an evolutionarily conserved arrangement of the cluster. Still, a marked difference distinguishes both genomes. While mt1 did not expand in mice, humans carry 13 arrayed duplicates (MT1A to MT1J, MT1L, MT1M and MT1X), five of which (MT1L, MT1J, MT1D, MT1C and MT1I) have been predicted to be no longer active forms. Overall, this corresponds to a genomic expansion of about 66 Kb in humans.

Figure 2
Illustration of the MT family in humans and mice.

Characterisation and divergence of mammalian MT proteins

Mammalian MTs are proteins with 20 invariant cysteines (Fig. 3A) which are responsible for the binding and sequestration of zinc (Zn), cadmium (Cd) and copper (Cu), among other metals. A total of 9 and 11 cysteines are required to form protein-domains that bind three and four ions (Fig. 3B). As documented previously [32], [33] and illustrated here (Fig. 3B), these residues are involved in metal binding through their thiol (-SH) moieties, which must be oriented towards the inside of the metal clusters whenever the ions are sequestered [34]. In humans and mice, MT1 and MT2 are 61-residue proteins (Fig. 3A). The MT3 holds an extra residue in the β domain (Thr5), which is important for its neuroinhibitory activity [35], [36], and a six-residue long insertion in the α domain, whereas MT4 shares an additional residue in the β domain (Glu5) (Fig. 3A).

Figure 3
Sequence comparison and structural features of MT proteins.

In order to obtain a clear picture of the amino acid conservation between all pairs of active MTs, identity scores were calculated in human/mouse comparisons (Fig. 4). As shown, MT2, MT3 and MT4 orthologues share 86%, 87% and 94% of residue identity, respectively. Among human MT1 duplicates, MT1E showed the highest identity (85%) with the mouse Mt1. Protein identity scores for MT3 resembles that observed in MT1 and MT2 while MT4 orthologues are strongly conserved in their aminoacid sequences (94% of residue identity between human and mouse). Previously, it was suggested that the preservation of MT4 sequence (only 4 out of 62 residues differed between human and mouse proteins) results from functional constraints [37] involved in epithelial cell differentiation [17]. Phylogenetic analyses (Fig. 1 and Figure S1) show that MT4 resulted from an old event of duplication and the high degree of sequence conservation between human and mouse orthologues strongly points to a role which seems to have been functionally important in mammalian evolution.

Figure 4
The amino acid identity matrix for human and mouse proteins.

About the pseudogenisation incidents

An important aspect related to the fate of a gene copy is the identification of the type of replacements leading to the pseudogenisation of functionally active genes. From its genomic sequence, we would be able to reconstruct the ancestral functional open reading frame and, at the same time, discern the panel of mutational events that have accumulated over time. To reconstruct the open reading frame of all the five MT1 pseudogenes, the corresponding genomic sequences were aligned with each of the MT1E exons separately, followed by manual inspection of sequence homology (Fig. 5). Because any attempt to disclose the impact of nonsynonymous replacements is not straightforward unless complemented with additional functional assays, we focused our attention on obvious damaging mutations, such as (a) replacement of invariant cysteine residues, (b) introduction of aromatic residues, as well as (c) premature stop codons, indels and mutations at the consensus donor (GT) or acceptor (AG) splice sites. Because these are shared features among all functional genes, our inferences are not constrained by the functional template that could have been chosen to infer the reading frame of each pseudogene.

Figure 5
The reconstructed open reading frame of MT1 pseudogenes.

We detected a total of 12 deleterious mutations within the predicted reading frame of MT1 pseudogenes, eight of which would result in the cysteine replacement and, in some cases, the inclusion of a premature stop codon (Cys5Tyr, Cys15Tyr, Cys24Tyr, Cys26X, Cys37Tyr, Cys41X, Cys50X, and Cys60Arg) covering MT1JP, MT1CP, MT1DP and MT1LP, three non-cysteine codons that would encode for an aromatic residue (Gly11Phe, Ser18Phe and Ser35Phe) in MT1IP and MT1CP, and a 1-bp deletion at the C-terminal domain in MT1IP. Since cysteine replacement either with tyrosine or with a stop codon involves only a single nucleotide substitution, these residues are expected to often contribute to MT pseudogeneization.

Outside the coding sequence, two mutations were found at the donor and acceptor splice site of MT1CP and MT1IP, respectively. Regarding the number of mutations, MT1CP is the pseudogene harbouring the highest number of events (six in total), followed by MT1IP and MT1DP (with three mutations each), MT1JP (two mutations) and finally by MT1LP, which would encode a truncated protein due to a premature stop codon.

Expression profile of the MT genes in humans and mice

Since gene duplication often results in a diversified spatiotemporal pattern of expression of duplicate family members [38], [39], [40], [41], [42] we next examined the MT transcription pattern using EST data for 30 human and mouse tissues as a metric of basal expression for all functional genes. Previous data have shown that MT1 and MT2 are ubiquitously expressed in both species whereas MT3 and MT4 present a confined expression in human and mouse brain [43] and in mouse epithelial tissue [17] respectively, although data regarding expression of MT4 in human tissues is still missing in the literature. The EST records were assembled in a diagram (Fig. 6A) that, in general terms, strongly overlaps the literature data. For instance, mouse mt1 and mt2 seem to be as widely expressed as the human MT2, a gene that has been proposed to have a housekeeping role for heavy metal homeostasis in every cell [44]. In humans, the expression pattern of MT2 clusters with MT1E and MT1X, the two duplicates that reveal the most wide pattern of basal expression [45]. The remaining genes revealed a more confined pattern of basal expression. For instance, constitutive expression of MT1B seems to be restricted to connective and blood tissues, whereas MT1A is highly expressed in the intestine and adipose tissue and less in uterus, eye, liver and lung. This analysis also rank MT1H, MT1F and MT1G in an intermediate position, showing a pattern that is not as wide as that of MT1E and MT1X but not so restricted as that of MTB, MT1A and MT1M either. Although the lack of ESTs in particular tissues may indicate difficulties to distinguish between different MT1 transcripts or bias in tissue representation, these caveats do not necessarily challenge the tissue-specificity generally observed in most MT1 duplicates, possibly playing distinct roles in distinct cell types as was suggested before [44], [46].

Figure 6
Expression profile of MT genes.

In contrast to MT1 and MT2, both MT3 and MT4 are constitutive tissue-specific isoforms that do not respond to metal-induction [17], [44], [47], [48], [49]. The EST data (Fig. 6) although supporting high expression of MT3 in human and mouse brain tissues also reveal abundant expression in other tissues as well.

Concerning the MT4 profile, EST records agree with previous findings that documented the stratified squamous epthitelium of digestive and reproductive systems as the main source of gene transcripts in mouse [17]. Thus far, no data exist on the expression of MT4 in humans (reviewed in [31]) and the EST surveillance has not detected expression in any tissue. These intriguing observations directed a more refined analysis concerning MT4 expression in humans that was here accomplished by RT-PCR in 15 human tissues. For comparative purposes we also assayed the expression of MT2 and MT3 in the same tissue collection (Fig. 6B). As expected, transcripts related with MT2 were observed in all tissues analysed. A similar scenario was observed for MT3 which is here demonstrated to be as ubiquitously expressed as is MT2. On the other hand, the detection of MT4 transcripts was only possible in four tissues (brain, testes, thymus and esophagus), with an evident higher expression in thymus, whose medullar component is mainly composed of epithelial cells [50]. Although the RT-PCR itself cannot provide exact quantitative inferences, it is possible to infer that in all the tissues where MT4 transcripts were detected, the expression level resulted lower than that of MT2 and MT3 with the exception of thymus.

Human polymorphic variability at the MT cluster

Although it is well established that functional MTs preserve a sequence with 20 invariants cysteines, no studies have thus far established the polymorphic status of the remaining residues. To achieve such information, we retrieved the available information on all human active proteins regarding nonsynonymous replacements (Table 1). Several nonsynonymous variants were found in MT1 duplicates and in MT2, but none is documented for MT3. Although a link between any of these replacements and a functional perturbation is not straightforward without complementary experimental assays, it should be mentioned that, in most of the cases the conserved cysteine residues remain unchanged and the replacement does not introduce an aromatic amino acid. The exceptions were observed in MT1B and MT4. In the MT1B case, a putative deleterious Cys19Ser (rs61744104) is indicated as polymorphic in humans although no additional data concerning the allelic frequencies are available in the databases. In the MT4 case, two candidate deleterious mutations were detected, Cys30Tyr (rs666636) and Arg31Trp (rs666647), both of which result in the introduction of aromatic amino acids along with the substitution of a critical cysteine at position 30. Taking into account the functional requisites of MTs, any of these mutations would ultimately result in an impaired metal-binding protein. In contrast with the MT1B case, allelic frequencies for these two polymorphisms are available and were retrieved from the HapMap (Table 2). Allelic frequencies of Cys30Tyr (rs666636) and Arg31Trp (rs666647) in 11 populations are presented in Table 2. In European populations up to 8,5% of the individuals carry a putatively deleterious allele. Frequencies are even higher in African and Asian populations (up to 30%). Genotype evaluation in all the populations showed that every chromosome that contains the Trp31 allele also contains the Tyr30, but not vice versa, which points to Cys30Tyr as the oldest variant and Arg31Trp as appearing afterwards in the same background.

Table 1
Nonsynonymous replacements at the human MT genes annotated in Ensembl database.
Table 2
Hapmap allelic frequencies of MT4 Tyr30 (rs666636) and Trp31 (rs666647) in human population.

Discussion

The history and fate of post-duplication events in the mammalian evolution was herein explored by the study of MT family members. After a duplication event, newly arisen genes can follow distinct evolutionary paths: if the parental gene is maintained active, redundant duplicates can escape purifying selection and start to accumulate loss-of-function mutations resulting in pseudogeneisation; less frequently, particular replacements may direct new genes into novel functions. Subfunctionalisation can also occur if parental and duplicates retain function but become distinct and complementary in their spatiotemporal pattern of expression.

Mammalian MT1 and MT2 are conserved proteins that play a critical role in heavy-metal homeostasis and are transcriptionally induced by metal [51] and glucocorticoids [52]. While most of the mammals show a single MT1 and MT2 copy that evolved through a duplication event, primates harbor multiple MT1 copies (Fig. 1). In humans, MT1 expansion resulted in a total of 13 tandemly arranged genes, five of which are known or predicted to be pseudogenes, while the remaining eight are still functionally active (Fig. 2). The pseudogeneization process has occurred by the accumulation of loss-of-function mutations mainly by replacing critical metal-binding cysteines or incorporated aromatic amino-acids in the protein sequence (Fig. 5). The most recently documented of these pseudogenes, MT1L [53], shows a unique mutation in which an invariant cysteine is replaced by a premature stop codon (Cys26Stop) resulting in a truncated protein.

Since its discovery [54], MT3 has been frequently associated with the protection against neuronal injury [15], [16]. The mammalian MT3 protein shows a characteristic insertion of six residues at the α-domain when compared to that of MT1 and MT2 (Fig. 3) and an extra residue in the β domain (Thr), which is responsible for neuron growth inhibitory activity in Alzheimer disease [35], [36]. Although the expression of MT3 has been almost exclusively related to brain tissues, we demonstrate that MT3 is a ubiquitously expressed gene. These results would drive future investigations on the involvement of MT3 in other cellular processes. In this regard, it is worth mentioning that Mt3 associates with other proteins in mouse brains as part of a multiprotein complex [55] suggesting function diversification and involvement in various physiological processes.

The most recently discovered family member, MT4, retains a high degree of conservation between humans and mice (Fig. 4), yet it shows the highest sequence divergence when compared with any other MT family member. However, the detection of structurally disrupting mutations at polymorphic proportions (Table 1) predicts that MT4 is inactive in some individuals. If that is the case, might the role of MT4 be performed by another family member? To address this possibility, the metal binding properties of MT4 were explored in the literature data. It has been shown that mouse Mt4 retains the capacity to bind Zn [17], [37], Cd and Cu as the ubiquitously expressed Mt1/Mt2, although the affinity to Cu is higher [37], [56]. Furthermore, it showed similar characteristic metal-thiolate clusters and solvent accessibility as Mt1 [57]. Extrapolating these properties to the human protein, for which no data of such detail are available, it is tempting to assume that the loss (pseudogeneization) of MT4 can be compensated by functional equivalents. In this context, MT1 and MT2 would be the most likely candidates for a number of reasons. First, the metal binding properties of Mt1 and Mt2 overlap that of Mt4 in mice [57]. Second, it has been demonstrated that some MT1 duplicates have cellular specificity [44], [46] and some of them are expressed in epithelium. Third, previous experiments in Drosophila melanogaster demonstrated that the number of functional gene duplications correlates to the resistance to Cd [13], [58] and Cu [13] as a direct consequence of the increased gene expression. Taken these data together, is thus possible that additional MT1 duplicates may have assumed the specialized role of the inactivated protein in humans. In such a case, it is likely that some MT1 genes may act as compensatory backup copies that replace MT4 in individuals carrying deleterious mutations. Accordingly, it is thus further possible to infer that the compensatory mechanism implies the regulation of gene expression as observed in D. melanogaster.

Tracing the evolutionary history of a gene after duplication often leaves more questions than answers. Some of those answers are easily obtained by direct read of DNA or protein sequences while some other depend on additional information which was here gathered for the MT family. Data on phylogeny, expression and intra-specific polymorphic information are necessary to drive hypotheses regarding the gain, loss and change of function of duplicated genes. The application of such a network of information, as is the case of this study, is thus necessary to extend the knowledge about the evolutionary fate of genes originated by duplication events.

Supporting Information

Figure S1

Maximum likelihood analysis of the MT family. The gene tree was constructed using coding sequences from the Ensembl database (Table S1). MT1/MT2, MT3 and MT4 clusters are represented in blue, red and green, respectively. Branch support was estimated by bootstrap. Scale bar: number of replacements per site.

(TIF)

Table S1

Metallothionein gene transcripts annotated in the Ensembl database (release 56, Sep 2009) as human orthologues of MT1E, MT1M, MT1A, MT1B, MT1F, MT1G, MT1H, MT1X, MT2, MT3 and MT4 in mammals. MT sequences from fishes, birds and reptiles are shown at the bottom of the table.

(DOC)

Footnotes

Competing Interests: The authors have declared that no competing interests exist.

Funding: This work was supported by Fundação para a Ciência e a Tecnologia grant (FCOMP-01-0124-FEDER-007167). LA, RM, and RS are supported by Fundação para a Ciência e a Tecnologia Ciência 2007 and by European Social Fund. Institute of Molecular Pathology and Immunology of the University of Porto is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by Fundação para a Ciência e a Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

1. Hughes AL. Adaptive evolution after gene duplication. Trends Genet. 2002;18:433–434. [PubMed]
2. Lynch M, Katju V. The altered evolutionary trajectories of gene duplicates. Trends Genet. 2004;20:544–549. [PubMed]
3. Lynch M. The origins of genome architecture. Sunderland: Sinauer Associates; 2007.
4. Ohno S. Evolution by gene duplication. Heidelberg: Springer-Verlag; 1970.
5. Ohta T. How gene families evolve. Theor Popul Biol. 1990;37:213–219. [PubMed]
6. Lynch M, Conery JS. The evolutionary fate and consequences of duplicate genes. Science. 2000;290:1151–1155. [PubMed]
7. Ohta T. Simulating evolution by gene duplication. Genetics. 1987;115:207–213. [PMC free article] [PubMed]
8. Prince VE, Pickett FB. Splitting pairs: the diverging fates of duplicated genes. Nat Rev Genet. 2002;3:827–837. [PubMed]
9. Force A, Lynch M, Pickett FB, Amores A, Yan YL, et al. Preservation of duplicate genes by complementary, degenerative mutations. Genetics. 1999;151:1531–1545. [PMC free article] [PubMed]
10. Lynch M, Force A. The probability of duplicate gene preservation by subfunctionalization. Genetics. 2000;154:459–473. [PMC free article] [PubMed]
11. Gu Z, Steinmetz LM, Gu X, Scharfe C, Davis RW, et al. Role of duplicate genes in genetic robustness against null mutations. Nature. 2003;421:63–66. [PubMed]
12. Ihmels J, Collins SR, Schuldiner M, Krogan NJ, Weissman JS. Backup without redundancy: genetic interactions reveal the cost of duplicate gene loss. Mol Syst Biol. 2007;3:86. [PMC free article] [PubMed]
13. Maroni G, Wise J, Young JE, Otto E. Metallothionein gene duplications and metal tolerance in natural populations of Drosophila melanogaster. Genetics. 1987;117:739–744. [PMC free article] [PubMed]
14. Egli D, Domenech J, Selvaraj A, Balamurugan K, Hua H, et al. The four members of the Drosophila metallothionein family exhibit distinct yet overlapping roles in heavy metal homeostasis and detoxification. Genes to Cells. 2006;11:647–658. [PubMed]
15. Chung RS, West AK. A role for extracellular metallothioneins in CNS injury and repair. Neuroscience. 2004;123:595–599. [PubMed]
16. Hozumi I, Inuzuka T, Hiraiwa M, Uchida Y, Anezaki T, et al. Changes of growth inhibitory factor after stab wounds in rat brain. Brain Res. 1995;688:143–148. [PubMed]
17. Quaife CJ, Findley SD, Erickson JC, Froelick GJ, Kelly EJ, et al. Induction of a New Metallothionein Isoform (MT-IV) Occurs during Differentiation of Stratified Squamous Epithelia. Biochemistry. 1994;33:7250–7259. [PubMed]
18. Villarreal L, Tío L, Capdevila M, Atrian S. Comparative metal binding and genomic analysis of the avian (chicken) and mammalian metallothionein. FEBS Journal. 2006;273:523–535. [PubMed]
19. Hubbard TJ, Aken BL, Ayling S, Ballester B, Beal K, et al. Ensembl 2009. Nucleic Acids Res. 2009;37:D690–697. [PMC free article] [PubMed]
20. Edgar RC. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics. 2004;5:113. [PMC free article] [PubMed]
21. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792–1797. [PMC free article] [PubMed]
22. Posada D. jModelTest: phylogenetic model averaging. Mol Biol Evol. 2008;25:1253–1256. [PubMed]
23. Drummond AJ, Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol. 2007;7:214. [PMC free article] [PubMed]
24. Rambaut A, Drummond AJ. 2007. Tracer v1.4 [ http://beast.bio.ed.ac.uk/Tracer]. [PMC free article] [PubMed]
25. Guindon S, Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol. 2003;52:696–704. [PubMed]
26. Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K, et al. Database resources of the National Center for Biotechnology Information. Nucl Acids Res. 2007;35:D5–12. [PMC free article] [PubMed]
27. Kasprzyk A, Keefe D, Smedley D, London D, Spooner W, et al. EnsMart: a generic system for fast and flexible access to biological data. Genome Res. 2004;14:160–169. [PMC free article] [PubMed]
28. Braun W, Vasak M, Robbins AH, Stout CD, Wagner G, et al. Comparison of the NMR solution structure and the x-ray crystal structure of rat metallothionein-2. Proc Natl Acad Sci U S A. 1992;89:10124–10128. [PMC free article] [PubMed]
29. Sali A, Blundell TL. Comparative Protein Modelling by Satisfaction of Spatial Restraints. Journal of Molecular Biology. 1993;234:779–815. [PubMed]
30. Azevedo L, Carneiro J, van Asch B, Moleirinho A, Pereira F, et al. Epistatic interactions modulate the evolution of mammalian mitochondrial respiratory complex components. BMC Genomics. 2009;10:266. [PMC free article] [PubMed]
31. Laukens D, Waeytens A, De Bleser P, Cuvelier C, De Vos M. Human metallothionein expression under normal and pathological conditions: mechanisms of gene regulation based on in silico promoter analysis. Crit Rev Eukaryot Gene Expr. 2009;19:301–317. [PubMed]
32. Waalkes MP, Goering PL. Metallothionein and other cadmium-binding proteins: recent developments. Chem Res in Toxicol. 1990;3:281–288. [PubMed]
33. Boulanger Y, Goodman CM, Forte CP, Fesik SW, Armitage IM. Model for mammalian metallothionein structure. Proc Natl Acad Sci U S A. 1983;80:1501–1505. [PMC free article] [PubMed]
34. Duncan KER, Ngu TT, Chan J, Salgado MT, Merrifield ME, et al. Peptide Folding, Metal-Binding Mechanisms, and Binding Site Structures in Metallothioneins. Exp Biol Med. 2006;231:1488–1499. [PubMed]
35. Cai B, Zheng Q, Teng X-C, Chen D, Wang Y, et al. The role of Thr5 in human neuron growth inhibitory factor. J Biol Inorg Chem. 2006;11:476–482. [PubMed]
36. Romero-Isart N, Jensen LT, Zerbe O, Winge DR, Vasak M. Engineering of Metallothionein-3 Neuroinhibitory Activity into the Inactive Isoform Metallothionein-1. J Biol Chem. 2002;277:37023–37028. [PubMed]
37. Tio L, Villarreal L, Atrian S, Capdevila M. Functional differentiation in the mammalian metallothionein gene family: metal binding features of mouse MT4 and comparison with its paralog MT1. J Biol Chem. 2004;279:24403–24413. [PubMed]
38. Greer JM, Puetz J, Thomas KR, Capecchi MR. Maintenance of functional equivalence during paralogous Hox gene evolution. Nature. 2000;403:661–665. [PubMed]
39. Gu Z, Rifkin SA, White KP, Li W-H. Duplicate genes increase gene expression diversity within and between species. Nat Genet. 2004;36:577–579. [PubMed]
40. Hamilton AT, Huntley S, Tran-Gyamfi M, Baggott DM, Gordon L, et al. Evolutionary expansion and divergence in the ZNF91 subfamily of primate-specific zinc finger genes. Genome Res. 2006;16:584–594. [PMC free article] [PubMed]
41. Byrne KP, Wolfe KH. Consistent patterns of rate asymmetry and gene loss indicate widespread neofunctionalization of yeast genes after whole-genome duplication. Genetics. 2007;175:1341–1350. [PMC free article] [PubMed]
42. Zou S, Kamei H, Modi Z, Duan C. Zebrafish IGF genes: gene duplication, conservation and divergence, and novel roles in midline and notochord development. PLoS One. 2009;4:e7026. [PMC free article] [PubMed]
43. Masters BA, Quaife CJ, Erickson JC, Kelly EJ, Froelick GJ, et al. Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J Neurosci. 1994;14:5844–5857. [PubMed]
44. Schmidt CJ, Hamer DH. Cell specificity and an effect of ras on human metallothionein gene expression. Proc Natl Acad Sci U S A. 1986;83:3346–3350. [PMC free article] [PubMed]
45. Stennard. 1994. Biochim Biophys Acta.
46. Cherian MG, Jayasurya A, Bay BH. Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res. 2003;533:201–209. [PubMed]
47. Haq F, Mahoney M, Koropatnick J. Signaling events for metallothionein induction. Mutat Res. 2003;533:211–226. [PubMed]
48. Vasak M, Hasler DW. Metallothioneins: new functional and structural insights. Curr Opin Chem Biol. 2000;4:177–183. [PubMed]
49. Karin M, Eddy RL, Henry WM, Haley LL, Byers MG, et al. Human metallothionein genes are clustered on chromosome 16. Proc Natl Acad Sci U S A. 1984;81:5494–5498. [PMC free article] [PubMed]
50. Rodewald HR, Paul S, Haller C, Bluethmann H, Blum C. Thymus medulla consisting of epithelial islets each derived from a single progenitor. Nature. 2001;414:763–768. [PubMed]
51. Beach LR, Palmiter RD. Amplification of the metallothionein-I gene in cadmium-resistant mouse cells. Proc Natl Acad Sci U S A. 1981;78:2110–2114. [PMC free article] [PubMed]
52. Hager LJ, Palmiter RD. Transcriptional regulation of mouse liver metallothionein-I gene by glucocorticoids. Nature. 1981;291:340–342. [PubMed]
53. Hahn Y, Lee B. Human-specific nonsense mutations identified by genome sequence comparisons. Human Genetics. 2006;119:169–178. [PubMed]
54. Palmiter RD, Findley SD, Whitmore TE, Durnam DM. MT-III, a brain-specific member of the metallothionein gene family. Proceedings of the National Academy of Sciences of the United States of America. 1992;89:6333–6337. [PMC free article] [PubMed]
55. Lahti DW, Hoekman JD, Tokheim AM, Martin BL, Armitage IM. Identification of mouse brain proteins associated with isoform 3 of metallothionein. Protein Sci. 2005;14:1151–1157. [PMC free article] [PubMed]
56. Meloni G, Zovo K, Kazantseva J, Palumaa P, Vasak M. Organization and assembly of metal-thiolate clusters in epithelium-specific metallothionein-4. J Biol Chem. 2006;281:14588–14595. [PubMed]
57. Cai B, Zheng Q, Huang Z-X. The properties of the metal–thiolate clusters in recombinant mouse metallothionein-4. Protein J. 2005;24:327–336. [PubMed]
58. Otto E, Young JE, Maroni G. Structure and expression of a tandem duplication of the Drosophila metallothionein gene. Proc Natl Acad Sci U S A. 1986;83:6025–6029. [PMC free article] [PubMed]
59. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl Acids Res. 1994;22:4673–4680. [PMC free article] [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...